Ardelyx Inc (ARDX)

6.43 +0.04 (+0.63%) USD  |  NASDAQ  |  Apr 24, 16:00
6.435 0.00 (0.00%) After-Hours: 20:00
More

Ardelyx Debt to Equity Ratio: 0.2987 for Dec. 31, 2023

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2013. Upgrade now.
Date Value
December 31, 2023 0.2987
September 30, 2023 0.1424
June 30, 2023 0.2196
March 31, 2023 0.2143
December 31, 2022 0.2716
September 30, 2022 0.397
June 30, 2022 0.4972
March 31, 2022 0.4072
December 31, 2021 0.3905
September 30, 2021 0.6321
June 30, 2021 0.4359
March 31, 2021 0.39
December 31, 2020 0.4027
September 30, 2020 0.3859
June 30, 2020 0.3447
March 31, 2020 0.2994
December 31, 2019 0.2679
September 30, 2019 1.013
June 30, 2019 0.7228
March 31, 2019 0.5379
December 31, 2018 0.4249
Date Value
September 30, 2018 0.3466
June 30, 2018 0.2988
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

0.1424
Minimum
Sep 2023
1.013
Maximum
Sep 2019
0.407
Average
0.39
Median
Mar 2021

Debt to Equity Ratio Benchmarks

Nektar Therapeutics 0.00
Omeros Corp --
Vistagen Therapeutics Inc 0.00
Karyopharm Therapeutics Inc -1.255
Adverum Biotechnologies Inc --

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 297.58M
Total Liabilities (Quarterly) 130.76M
Shareholders Equity (Quarterly) 166.82M
Current Ratio 4.884
Net Debt Paydown Yield -0.32%